Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Targeting syndecans: a promising strategy for the treatment of cancer.

Choi S, Kang DH, Oh ES.

Expert Opin Ther Targets. 2013 Jun;17(6):695-705. doi: 10.1517/14728222.2013.773313. Epub 2013 Feb 19. Review.

PMID:
23421390
[PubMed - indexed for MEDLINE]
2.

Shedding; towards a new paradigm of syndecan function in cancer.

Choi S, Lee H, Choi JR, Oh ES.

BMB Rep. 2010 May;43(5):305-10. Review.

PMID:
20510012
[PubMed - indexed for MEDLINE]
Free Article
3.

Syndecans play dual roles as cell adhesion receptors and docking receptors.

Kwon MJ, Jang B, Yi JY, Han IO, Oh ES.

FEBS Lett. 2012 Jul 30;586(16):2207-11. doi: 10.1016/j.febslet.2012.05.037. Epub 2012 May 31. Review.

PMID:
22659189
[PubMed - indexed for MEDLINE]
Free Article
4.

Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target.

Krasnov GS, Dmitriev AA, Snezhkina AV, Kudryavtseva AV.

Expert Opin Ther Targets. 2013 Jun;17(6):681-93. doi: 10.1517/14728222.2013.775253. Epub 2013 Feb 28. Review.

PMID:
23445303
[PubMed - indexed for MEDLINE]
5.

Differential expression of syndecan isoforms during mouse incisor amelogenesis.

Muto T, Miyoshi K, Munesue S, Nakada H, Okayama M, Matsuo T, Noma T.

J Med Invest. 2007 Aug;54(3-4):331-9.

PMID:
17878683
[PubMed - indexed for MEDLINE]
Free Article
6.

Proteoglycans in health and disease: the multiple roles of syndecan shedding.

Manon-Jensen T, Itoh Y, Couchman JR.

FEBS J. 2010 Oct;277(19):3876-89. doi: 10.1111/j.1742-4658.2010.07798.x. Epub 2010 Aug 31. Review.

PMID:
20840585
[PubMed - indexed for MEDLINE]
7.

Syndecans shed their reputation as inert molecules.

Bass MD, Morgan MR, Humphries MJ.

Sci Signal. 2009 Mar 31;2(64):pe18. doi: 10.1126/scisignal.264pe18. Review.

PMID:
19336838
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer.

Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):627-38.

PMID:
19822079
[PubMed - indexed for MEDLINE]
9.

Osteopontin: a potentially important therapeutic target in cancer.

Ahmed M, Behera R, Chakraborty G, Jain S, Kumar V, Sharma P, Bulbule A, Kale S, Kumar S, Mishra R, Raja R, Saraswati S, Kaur R, Soundararajan G, Kumar D, Thorat D, Sanyal M, Ramdasi A, Ghosh P, Kundu GC.

Expert Opin Ther Targets. 2011 Sep;15(9):1113-26. doi: 10.1517/14728222.2011.594438. Epub 2011 Jul 25. Review.

PMID:
21718227
[PubMed - indexed for MEDLINE]
10.

Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules.

Salmivirta M, Jalkanen M.

Experientia. 1995 Sep 29;51(9-10):863-72. Review.

PMID:
7556568
[PubMed - indexed for MEDLINE]
11.

Syndecans: multifunctional cell-surface co-receptors.

Carey DJ.

Biochem J. 1997 Oct 1;327 ( Pt 1):1-16. Review.

PMID:
9355727
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting HER receptors in cancer.

Ocaña A, Pandiella A.

Curr Pharm Des. 2013;19(5):808-17. Review.

PMID:
22973952
[PubMed - indexed for MEDLINE]
13.

Syndecans as receptors and organizers of the extracellular matrix.

Xian X, Gopal S, Couchman JR.

Cell Tissue Res. 2010 Jan;339(1):31-46. doi: 10.1007/s00441-009-0829-3. Epub 2009 Jul 14. Review.

PMID:
19597846
[PubMed - indexed for MEDLINE]
14.

Cancer stem cells: the development of new cancer therapeutics.

Scatena R, Bottoni P, Pontoglio A, Giardina B.

Expert Opin Biol Ther. 2011 Jul;11(7):875-92. doi: 10.1517/14712598.2011.573780. Epub 2011 Mar 30. Review.

PMID:
21463158
[PubMed - indexed for MEDLINE]
15.

The signaling mechanisms of syndecan heparan sulfate proteoglycans.

Lambaerts K, Wilcox-Adelman SA, Zimmermann P.

Curr Opin Cell Biol. 2009 Oct;21(5):662-9. doi: 10.1016/j.ceb.2009.05.002. Epub 2009 Jun 15. Review.

PMID:
19535238
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Syndecans in wound healing, inflammation and vascular biology.

Alexopoulou AN, Multhaupt HA, Couchman JR.

Int J Biochem Cell Biol. 2007;39(3):505-28. Epub 2006 Oct 28. Review.

PMID:
17097330
[PubMed - indexed for MEDLINE]
17.

The role of syndecans in the regulation of body weight and synaptic plasticity.

Reizes O, Benoit SC, Clegg DJ.

Int J Biochem Cell Biol. 2008;40(1):28-45. Epub 2007 Jun 30. Review.

PMID:
17698399
[PubMed - indexed for MEDLINE]
18.

Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.

Simon M, Stefan N, Plückthun A, Zangemeister-Wittke U.

Expert Opin Drug Deliv. 2013 Apr;10(4):451-68. doi: 10.1517/17425247.2013.759938. Epub 2013 Jan 14. Review.

PMID:
23316711
[PubMed - indexed for MEDLINE]
19.

Unlocking the secrets of syndecans: transgenic organisms as a potential key.

Bellin R, Capila I, Lincecum J, Park PW, Reizes O, Bernfield MR.

Glycoconj J. 2002 May-Jun;19(4-5):295-304. Review.

PMID:
12975608
[PubMed - indexed for MEDLINE]
20.

Syndecans as cell surface receptors: Unique structure equates with functional diversity.

Choi Y, Chung H, Jung H, Couchman JR, Oh ES.

Matrix Biol. 2011 Mar;30(2):93-9. doi: 10.1016/j.matbio.2010.10.006. Epub 2010 Nov 6. Review.

PMID:
21062643
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk